Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.01 USD | -0.41% | +62.03% | +165.06% |
Apr. 29 | Cullinan Therapeutics Appoints Mary Kay Fenton as CFO | MT |
Apr. 29 | Cullinan Therapeutics, Inc Appoints Mary Kay Fenton as Chief Financial Officer | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 8.45M | Capitalization | 1.16B |
---|---|---|---|---|---|
Net income 2024 * | -173M | Net income 2025 * | -178M | EV / Sales 2024 * | - |
Net cash position 2024 * | 619M | Net cash position 2025 * | 538M | EV / Sales 2025 * | 74 x |
P/E ratio 2024 * |
-8.07
x | P/E ratio 2025 * |
-8.98
x | Employees | 85 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.6% |
Latest transcript on Cullinan Therapeutics, Inc.
1 day | -0.41% | ||
1 week | +62.03% | ||
1 month | +58.51% | ||
3 months | +78.40% | ||
6 months | +189.50% | ||
Current year | +165.06% |
Managers | Title | Age | Since |
---|---|---|---|
Nadim Ahmed
CEO | Chief Executive Officer | 56 | 21-10-17 |
Jeffrey Jones
CTO | Chief Tech/Sci/R&D Officer | 53 | 22-02-27 |
Jacquelyn Sumer
CMP | Compliance Officer | 46 | 22-08-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 71 | 17-07-31 | |
Thomas Ebeling
BRD | Director/Board Member | 65 | 17-07-31 |
Stephen Webster
BRD | Director/Board Member | 63 | 20-08-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.03% | 0 M€ | 0.00% | - | |
0.03% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 27.01 | -0.41% | 1,104,681 |
24-04-29 | 27.12 | +7.19% | 2,703,008 |
24-04-26 | 25.3 | +31.43% | 4,747,718 |
24-04-25 | 19.25 | +1.91% | 1,550,075 |
24-04-24 | 18.89 | +13.32% | 1,173,778 |
Delayed Quote Nasdaq, April 30, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+165.06% | 1.17B | |
+0.17% | 42.86B | |
+10.92% | 42.74B | |
+44.30% | 41.36B | |
-6.20% | 27.68B | |
+5.23% | 25.15B | |
-24.79% | 18.63B | |
+26.69% | 12.37B | |
-3.13% | 11.92B | |
+6.57% | 11.21B |
- Stock Market
- Equities
- CGEM Stock